Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Journal of Medicinal Chemistry|February 3, 2007
Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2)Jakub Fichna, Jean-Claude do-Rego, Nga N Chung, et al.Fundamental & Clinical Pharmacology|November 18, 2006
Hypericum caprifoliatum (Guttiferae) Cham. & Schltdl.: a species native to South Brazil with antidepressant-like activityAlice F Viana, Jean-Claude do Rego, Leonardo Munari, et al.Psychoneuroendocrinology|October 10, 2008
Regulation of feeding and anxiety by alpha-MSH reactive autoantibodiesMaria Hamze Sinno, Jean Claude Do Rego, Moïse Coëffier, et al.Journal of Medicinal Chemistry|June 1, 2011
Structure-activity relationships of a series of analogues of the RFamide-related peptide 26RFaOlivier Le Marec, Cindy Neveu, Benjamin Lefranc, et al.Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activityNicolas Chartrel, Cynthia Dujardin, Youssef Anouar, et al.Behavioural Brain Research|December 14, 2011
Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugsAna C Stein, Alice F Viana, Liz G Müller, et al.Parkinsonism & Related Disorders|November 13, 2013
Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's diseaseDavid Devos, Stéphanie Lejeune, Florence Cormier-Dequaire, et al.Peptides|March 7, 2006
Structure and functions of the novel hypothalamic RFamide neuropeptides R-RFa and 26RFa in vertebratesNicolas Chartrel, Federica Bruzzone, Jérôme Leprince, et al.Journal of Medicinal Chemistry|July 18, 2012
Rational design of a low molecular weight, stable, potent, and long-lasting GPR103 aza-β3-pseudopeptide agonistCindy Neveu, Benjamin Lefranc, Olivier Tasseau, et al.Annals of Neurology|February 1, 2011
The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trialJean-Christophe Corvol, Cécilia Bonnet, Fanny Charbonnier-Beaupel, et al.Pageof 7